Proof of Quality & COAs
Quality you can trace.
Review approved public records linked to listed materials and products. Each record identifies its scope, lot or batch, document date, and the values reported in the source document—so you can read the record rather than rely on a broad claim.
Find a quality recordRecords are displayed only when approved for public release.
The quality record path
Documentation that follows the record—not a slogan.
Current approved public records are shown with their exact scope. Ingredient, finished-product, and delivery-stage records are shown separately when approved evidence is available.
Raw Peptide Powder Testing
Approved supplier-issued Certificates of Analysis are published for identified incoming-material lots where applicable. The record library shows only the parameters and values reported by the source document.
Finished Product Testing
Finished-product batch records are published separately for exact tested batches only when approved evidence is available.
Cold Chain Logistics
Route-specific storage and shipment records are published only when approved evidence documents the stated conditions.
How to read a quality record
Match the record to the item first.
Check the exact product or ingredient, variant, lot or batch, issuer, document date, reported method, and reported values. A raw-ingredient record does not by itself establish that a finished product, blend, or delivery route was tested.
Peptide information
Reference topics and product navigation
This section uses a supplied educational reference only for peptide naming and broad topic organization. It intentionally does not reproduce its patient-information, dosing, indication, benefit, or therapeutic statements.
Metabolic research topics
The supplied reference groups semaglutide, tirzepatide, retatrutide, AOD-9604, and MOTS-c under weight-management or metabolism-oriented discussion. Listed-product availability is controlled separately by the catalogue.
Browse relevant listed optionsPerformance and growth-hormone topics
The reference groups CJC-1295, Ipamorelin, Tesamorelin, and IGF-1 LR3 in a performance and growth-hormone topic area. This site does not provide dosing or use guidance.
Search listed optionsRecovery and material topics
The reference includes BPC-157, TB-500, and KPV in a recovery topic area. Product selection remains a catalogue and documentation matter; no medical, therapeutic, or suitability claim is made here.
Search listed optionsFocus, mood, longevity and rest topics
The supplied material discusses Melanotan 2, SEMAX, SELANK, Epithalon, and DSIP in focus/mood, longevity, rest, or aesthetics topic areas. The page provides only a navigation and documentation framework.
Search listed optionsResearch-material limitation: Reference topics and public documents are supplied for product-information and traceability review only. They do not establish medical use, therapeutic benefit, dosing, regulatory approval, safety for human or animal use, or suitability for any purpose.
Latest COAs by listed product
Review the latest COAs by product.
For each approved public record, the reported content and purity values are displayed before the record details and on applicable catalogue cards. These values are transcribed from the specific COA rather than calculated or inferred by the site.
Raw Ingredient and Post-Manufacture COAs
Supplier-issued records associated with incoming ingredient lots. The full PDF retains the issuing laboratory’s complete reported parameters, while the record highlight shows its relevant reported content and purity results up front.
Latest COAs by product
Two COA levels, organized by listed product.
Each product below shows only its latest approved public Raw Ingredient COA and Post-Manufacture COA where available. No historical document archive is provided on this site.
Raw Ingredient COA
No approved public COA is currently displayed for this level.
Post-Manufacture COA
No approved public COA is currently displayed for this level.
Listed product
BPC-157 + TB-500 aka Wolverine (50/50)
Latest approved public COA records for this listed product.
Raw Ingredient COA
No approved public COA is currently displayed for this level.
Post-Manufacture COA
No approved public COA is currently displayed for this level.
Raw Ingredient COA
No approved public COA is currently displayed for this level.
Post-Manufacture COA
No approved public COA is currently displayed for this level.
Raw Ingredient COA
No approved public COA is currently displayed for this level.
Post-Manufacture COA
No approved public COA is currently displayed for this level.
Raw Ingredient COA
Reported COA highlights
- GHK content
- 68.7%
- Copper content
- 13.8%
- Purity
- 99.8%
GHK-Cu — Raw Ingredient COA — 2026-02-07
- Lot / batch
- 20260207
- Document date
- February 7, 2026
- Record ID
- EZP-RI-GHKCU-20260207
Post-Manufacture COA
No approved public COA is currently displayed for this level.
Raw Ingredient COA
Reported COA highlights
- Peptide Content
- 93.6%
- Purity
- 99.1%
Retatrutide — Raw Ingredient COA — 2026-04-30
- Lot / batch
- 20260430
- Document date
- April 30, 2026
- Record ID
- EZP-RI-RETA-20260430
Post-Manufacture COA
No approved public COA is currently displayed for this level.
Raw Ingredient COA
No approved public COA is currently displayed for this level.
Post-Manufacture COA
No approved public COA is currently displayed for this level.
Listed product
IPA + CJC-1295 No DAC (60 IPA / 40 CJC-1295 No DAC)
Latest approved public COA records for this listed product.
Raw Ingredient COA
No approved public COA is currently displayed for this level.
Post-Manufacture COA
No approved public COA is currently displayed for this level.
Listed product
KLOW (10 KPV / 10 BPC-157 / 10 TB-500 / 50 GHK-Cu)
Latest approved public COA records for this listed product.
Raw Ingredient COA
Reported COA highlights
- GHK content
- 68.7%
- Copper content
- 13.8%
- Purity
- 99.8%
GHK-Cu — Raw Ingredient COA — 2026-02-07
- Lot / batch
- 20260207
- Document date
- February 7, 2026
- Record ID
- EZP-RI-GHKCU-20260207
Post-Manufacture COA
No approved public COA is currently displayed for this level.
Raw Ingredient COA
No approved public COA is currently displayed for this level.
Post-Manufacture COA
No approved public COA is currently displayed for this level.
Raw Ingredient COA
No approved public COA is currently displayed for this level.
Post-Manufacture COA
No approved public COA is currently displayed for this level.
Raw Ingredient COA
No approved public COA is currently displayed for this level.
Post-Manufacture COA
No approved public COA is currently displayed for this level.
Raw Ingredient COA
No approved public COA is currently displayed for this level.
Post-Manufacture COA
No approved public COA is currently displayed for this level.
Raw Ingredient COA
No approved public COA is currently displayed for this level.
Post-Manufacture COA
No approved public COA is currently displayed for this level.
Raw Ingredient COA
No approved public COA is currently displayed for this level.
Post-Manufacture COA
No approved public COA is currently displayed for this level.
Raw Ingredient COA
No approved public COA is currently displayed for this level.
Post-Manufacture COA
No approved public COA is currently displayed for this level.
Raw Ingredient COA
No approved public COA is currently displayed for this level.
Post-Manufacture COA
No approved public COA is currently displayed for this level.
Raw Ingredient COA
Reported COA highlights
- Peptide Content
- 95.5%
- Purity
- 99.5%
Tirzepatide — Raw Ingredient COA — 2026-01-17
- Lot / batch
- 20260117
- Document date
- January 17, 2026
- Record ID
- EZP-RI-TIRZ-20260117
Post-Manufacture COA
No approved public COA is currently displayed for this level.
Documentation limitation: Records are provided for document traceability and should be read in the context of the identified material or lot. They do not establish medical use, therapeutic benefit, regulatory approval, safety for human or animal use, or suitability for any purpose.
Document questions
Need help locating a COA or other document?
Support can help locate a document or help provide clarifications. It cannot provide medical, dosing, safety, therapeutic, or suitability guidance.
Contact support